期刊
JOURNAL OF INTERNAL MEDICINE
卷 255, 期 2, 页码 159-178出版社
WILEY
DOI: 10.1046/j.1365-2796.2003.01262.x
关键词
amyloid; amyloidosis; fibril protein; systemic amyloidosis
资金
- Telethon [E.0793] Funding Source: Medline
Knowledge about the systemic amyloidoses has increased considerably during the last few years. This group of diseases is characterized by great biochemical variability, including at least 11 different amyloid fibril proteins and a remarkable range of clinical manifestations. With the understanding that the pathogenesis is different in the various forms of amyloidosis, it is now being increasingly accepted that an early and accurate diagnosis, including that of the underlying biochemical nature, is crucial for a successful treatment. The elucidation of the molecular mechanisms involved in amyloidogenesis is at the basis of the recent blossoming of new, innovative and more effective therapeutic approaches.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据